Luis Aparicio
Impact in
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Gastric Cancer Management and Outcomes
Papers in
-
- Prostate Cancer Treatment and Research 12
- Renal cell carcinoma treatment 8
-
- Renal and related cancers 5
- Hedgehog Signaling Pathway Studies 4
- Bioinformatics and Genomic Networks 4
- Co-authors
- Enrique Grande Pulido (4 shared papers)Rosario García Campelo (9 shared papers)Javier Espinosa (3 shared papers)Ángel J. Lacave (2 shared papers)Isabel Izarzugaza (2 shared papers)Javier Marco (2 shared papers)M.R. García Campelo (1 shared paper)Javier Cassinello (1 shared paper)
- Journals
- Clinical & Translational Oncology (11 papers)Journal of Clinical Oncology (11 papers)Anti-Cancer Drugs (3 papers)Annals of Oncology (2 papers)Expert Opinion on Drug Safety (1 paper)
- Partner nations
- SpainUnited KingdomItaly
In The Last Decade
Luis Aparicio
45 papers receiving 491 citations
Peers
Comparison fields: 5 of 74
- Pulmonary and Respiratory Medicine 213
- Cancer Research 90
- Oncology 163
- Small Animals 22
- Molecular Biology 204
Countries citing papers authored by Luis Aparicio
This map shows the geographic impact of Luis Aparicio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Aparicio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Aparicio more than expected).
Fields of papers citing papers by Luis Aparicio
This network shows the impact of papers produced by Luis Aparicio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Aparicio. The network helps show where Luis Aparicio may publish in the future.
Co-authors
The 25 scholars most cited alongside Luis Aparicio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 50 | |
| 2 | 1983 | 43 | |
| 3 | 2011 | 42 | |
| 4 | 2014 | 39 | |
| 5 | 2017 | 22 | |
| 6 | 2009 | 22 | |
| 7 | 2014 | 22 | |
| 8 | 2008 | 20 | |
| 9 | 2004 | 20 | |
| 10 | 2011 | 18 | |
| 11 | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 2011 | 18 |
| 12 | 2009 | 17 | |
| 13 | 2007 | 16 | |
| 14 | 2013 | 15 | |
| 15 | 2012 | 14 | |
| 16 | 2012 | 13 | |
| 17 | 2015 | 10 | |
| 18 | 2020 | 10 | |
| 19 | 1985 | 9 | |
| 20 | 2007 | 8 |
About Luis Aparicio
Luis Aparicio is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 48 papers that have together received 503 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Renal cell carcinoma treatment (8 papers), Cancer Treatment and Pharmacology (7 papers), Cancer Genomics and Diagnostics (6 papers), Renal and related cancers (5 papers), Cancer, Lipids, and Metabolism (4 papers), Hedgehog Signaling Pathway Studies (4 papers) and Bioinformatics and Genomic Networks (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (213 citations), Cancer Research (90 citations), Oncology (163 citations), Small Animals (22 citations) and Molecular Biology (204 citations). Luis Aparicio has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Enrique Grande Pulido, Rosario García Campelo, Javier Espinosa, Ángel J. Lacave, Isabel Izarzugaza, Javier Marco, M.R. García Campelo, Javier Cassinello, J. Buesa and Irina Fernandez. Their work appears in journals such as Clinical & Translational Oncology, Journal of Clinical Oncology, Anti-Cancer Drugs, Annals of Oncology and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.